{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:00:43Z","timestamp":1789635643635,"version":"4.0.0"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["143342"],"award-info":[{"award-number":["143342"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["168228"],"award-info":[{"award-number":["168228"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Non-adherence to tuberculosis (TB) treatment poses a significant challenge to effective TB management globally and is a major contributor to the emergence of multidrug-resistant TB. Although adherence to TB treatment has been widely studied, a comprehensive evaluation of the comparative levels of adherence in high- versus low-TB burden settings remains lacking. The objective of this systematic review and meta-analysis is to assess the levels of adherence to TB treatment in high-TB burden countries compared to low-burden countries. Additionally, it seeks to identify the unique facilitators and barriers to treatment adherence in these distinct settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols Statement. Using key medical subject heading terms and free-text terms related to TB treatment adherence, a systematic search of the literature will be performed in Medline, Embase, CINAHL, Scopus, Global Health and the Cochrane Databases of Systematic Reviews. A medical librarian will assist with developing the search strategy. Two independent reviewers will independently screen studies against predefined inclusion and exclusion criteria at both the title\/abstract and full-text stages. Working in duplicate, the same two reviewers will independently extract relevant study and outcomes data, including study descriptors, TB burden, adherence levels and adherence measures, from eligible studies. Countries will be classified according to TB burden based on the WHO\u2019s high-burden country list from the post-2015 era (2015\u20132025). The quality of the included studies will be appraised using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale. Qualitative data will be appraised using the Critical Appraisal Skills Programme tool. Studies will be pooled using the DerSimonian-Laird random-effects meta-analysis. Additionally, a meta-synthesis of the qualitative data from the included studies may be conducted to identify emergent themes related to facilitators and barriers of TB treatment adherence in high- vs low-TB burden countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval is not required for this study as it does not involve the recruitment or collection of data from participants. The findings from this systematic review and meta-analysis will be disseminated through publication in peer-reviewed journals, presentations at scientific conferences, and via social media channels to enhance visibility, particularly within programmatic and policy spheres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42021273336<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-089507","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T06:45:33Z","timestamp":1737787533000},"page":"e089507","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to tuberculosis (TB) treatment in high compared to low TB burden countries: study protocol for a systematic review and meta-analysis with a qualitative meta-synthesis of themes"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-1076","authenticated-orcid":false,"given":"Oghenowede","family":"Eyawo","sequence":"first","affiliation":[{"name":"School of Global Health, York University, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnette Nathalie","family":"Lyzwinski","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchechukwu Chidiebere","family":"Ugoji","sequence":"additional","affiliation":[{"name":"Salem Clinic and Maternity, Warri, Delta State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-0095","authenticated-orcid":false,"given":"Setor Kofi","family":"Sorkpor","sequence":"additional","affiliation":[{"name":"Florida State University College of Nursing, Tallahassee, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prekeyi","family":"Tawari-Fufeyin","sequence":"additional","affiliation":[{"name":"Department of Environmental Management, Hensard University, Toru-Orua, Bayelsa, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Hogg","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada"},{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"2025121410211432000_15.1.e089507.1","unstructured":"World Health Organization (WHO) . Global tuberculosis report 2023. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports [Accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.37.4.246"},{"key":"2025121410211432000_15.1.e089507.3","unstructured":"World Health Organization (WHO) . Tuberculosis: overview 2024. Available: https:\/\/www.who.int\/health-topics\/tuberculosis#tab=tab_1 [Accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.4","unstructured":"World Health Organization (WHO) . Tuberculosis: world health organization. 2023. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis [Accessed 14 May 2024]."},{"key":"2025121410211432000_15.1.e089507.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017601","article-title":"Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review","volume":"6","author":"Tiemersma","year":"2011","journal-title":"PLoS ONE"},{"key":"2025121410211432000_15.1.e089507.6","unstructured":"World Health Organization (WHO) . WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment. 2022. Available: https:\/\/iris.who.int\/handle\/10665\/353829 [Accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.7","unstructured":"World Health Organization (WHO) . WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. 2022. Available: https:\/\/iris.who.int\/handle\/10665\/365308 [Accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.8","unstructured":"World Health Organization . Tuberculosis handbook. world health organization document WHO\/TB 98253. Geneva: World Health Organization, 1998:1\u2013222."},{"key":"2025121410211432000_15.1.e089507.9","unstructured":"World Health Organization . What is DOTS? a guide to understanding the WHO-recommended TB control strategy known as DOTS. world health organization document WHO\/CDC\/CPC\/TB 99270. Geneva: World Health Organization, 1999:1\u201339."},{"key":"2025121410211432000_15.1.e089507.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med"},{"key":"2025121410211432000_15.1.e089507.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002884","article-title":"The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials","volume":"16","author":"Vernon","year":"2019","journal-title":"PLoS Med"},{"key":"2025121410211432000_15.1.e089507.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: a systematic review of qualitative research","volume":"4","author":"Munro","year":"2007","journal-title":"PLoS Med"},{"key":"2025121410211432000_15.1.e089507.13","first-page":"1","article-title":"Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review","volume":"44","author":"Tola","year":"2015","journal-title":"Iran J Public Health"},{"key":"2025121410211432000_15.1.e089507.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219470","article-title":"Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique","volume":"14","author":"De Schacht","year":"2019","journal-title":"PLoS ONE"},{"key":"2025121410211432000_15.1.e089507.15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4269\/ajtmh.17-0383","article-title":"Nonadherence to Antituberculosis Medications: The Impact of Stigma and Depressive Symptoms","volume":"98","author":"Yan","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2025121410211432000_15.1.e089507.16","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-393","article-title":"Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review","volume":"11","author":"Long","year":"2011","journal-title":"BMC Public Health"},{"key":"2025121410211432000_15.1.e089507.17","unstructured":"World Health Organization (WHO) . WHO consolidated guidelines on tuberculosis: module 1: prevention \u2013 infection prevention and control. Geneva: World Health Organization, 2022. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK586286\/ [accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30024-8"},{"key":"2025121410211432000_15.1.e089507.19","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12067"},{"key":"2025121410211432000_15.1.e089507.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047533","article-title":"Tuberculosis and poverty: why are the poor at greater risk in India?","volume":"7","author":"Oxlade","year":"2012","journal-title":"PLoS ONE"},{"key":"2025121410211432000_15.1.e089507.21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00214014"},{"key":"2025121410211432000_15.1.e089507.22","doi-asserted-by":"publisher","DOI":"10.3201\/eid1809.120128"},{"key":"2025121410211432000_15.1.e089507.23","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.058453"},{"key":"2025121410211432000_15.1.e089507.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0595-5","article-title":"The impact of migration on tuberculosis epidemiology and control in high-income countries: a review","volume":"14","author":"Pareek","year":"2016","journal-title":"BMC Med"},{"key":"2025121410211432000_15.1.e089507.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025121410211432000_15.1.e089507.26","unstructured":"McKenzie JE , Brennan SE , Ryan RE , et al . Chapter 3: defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT , Thomas J , Chandler J , eds. Cochrane Handbook for Systematic Reviews of Interventions version 64. 2023."},{"key":"2025121410211432000_15.1.e089507.27","unstructured":"World Health Organization (WHO) . WHO releases new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB: World health organization. 2021. Available: https:\/\/www.who.int\/news\/item\/17-06-2021-who-releases-new-global-lists-of-high-burden-countries-for-tb-hiv-associated-tb-and-drug-resistant-tb [Accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.28","unstructured":"Stop TB Patnership . High burden countries for tuberculosis 2021. Available: https:\/\/www.stoptb.org\/securing-quality-tb-care-all\/high-burden-countries-tuberculosis [Accessed 17 May 2024]."},{"key":"2025121410211432000_15.1.e089507.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.93.04101288"},{"key":"2025121410211432000_15.1.e089507.30","unstructured":"World Bank . The world by income and region 2024. Available: https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html [Accessed 21 May 2024]."},{"key":"2025121410211432000_15.1.e089507.31","unstructured":"World Bank . World bank country and lending groups. 2024. Available: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups?_gl=1*zlcgt2*_gcl_au*MTAxOTU0ODM1NS4xNzI3MTk4MTQ5 [Accessed 24 Sep 2024]."},{"key":"2025121410211432000_15.1.e089507.32","unstructured":"Higgins JPT , Savovi\u0107 J , Page MJ , et al . Chapter 8: assessing risk of bias in a randomized trial. In: Higgins JPT , Thomas J , Chandler J , eds. Cochrane Handbook for Systematic Reviews of Interventions version 64. 2023."},{"key":"2025121410211432000_15.1.e089507.33","unstructured":"Wells GA , Shea B , O\u2019Connell D , et al . The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2018. Available: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [Accessed 22 May 2024]."},{"key":"2025121410211432000_15.1.e089507.34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/0976-500X.107697","article-title":"Critical appraisal skills programme","volume":"4","author":"Singh","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"2025121410211432000_15.1.e089507.35","unstructured":"Critical Appraisal Skills Programme . CASP qualitative studies checklist 2018. Available: https:\/\/casp-uk.net\/casp-tools-checklists\/ [Accessed 22 May 2024]."},{"key":"2025121410211432000_15.1.e089507.36","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025121410211432000_15.1.e089507.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121410211432000_15.1.e089507.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-019-0670-7","article-title":"A methodological systematic review of meta-ethnography conduct to articulate the complex analytical phases","volume":"19","author":"France","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"2025121410211432000_15.1.e089507.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-089507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:21:24Z","timestamp":1765736484000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-089507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,25]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-089507"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-089507","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}